New Key Statistics Module, Z-Score and F-Score
NAS:BCRX Key Ratios
Market Cap $ M | 872.02 |
Enterprise Value $ M | 1,293.74 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 2.48 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 331.00 |
EPS (TTM) $ | -1.18 |
Beneish M-Score | -3.57 |
10-y EBITDA Growth Rate % | -4.10 |
5-y EBITDA Growth Rate % | 6.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.96 |
EV-to-EBITDA | -11.12 |
PEG | -- |
Shares Outstanding M | 206.15 |
Net Margin (%) | -68.36 |
Operating Margin % | -31.29 |
Pre-tax Margin (%) | -68.26 |
Quick Ratio | 3.12 |
Current Ratio | 3.31 |
ROA % (ttm) | -43.08 |
ROE % (ttm) | -- |
ROIC % (ttm) | -184.59 |
Dividend Yield % | -- |
Altman Z-Score | -3.33 |
BCRX Number of Guru Trades
BCRX Volume of Guru Trades
Gurus Latest Trades with NAS:BCRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BCRX is held by these investors
Total 1
BioCryst Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:BCRX
Total 0- 1